To evaluate in vivo sentinel lymph node (SLN) mapping by using photoacoustic and ultrasonographic (US) imaging with a modifi ed clinical US imaging system.
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Erpelding et al tumors, and internal organs) ( 24, 25 ) and function (eg, tumor hypoxia and dynamic brain activities) ( 18, 19, 26, 27 ) . Moreover, exogenous contrast agents, such as organic dyes, nanoparticles, reporter genes, and fl uorescent proteins, have enabled photoacoustic molecular imaging ( 26, (28) (29) (30) (31) . A tabletop photoacoustic imaging system that is based on mechanical raster scanning has been applied to identify rat SLNs in vivo by using methylene blue dye, gold nanoparticles, and single-walled carbon nanotubes (32) (33) (34) (35) . However, the imaging speed of this system (approximately 8 minutes for a 24 3 24-mm 2 fi eld of view) limits its clinical applicability owing to mechanical scanning.
Our purpose was to evaluate in vivo SLN mapping by using photoacoustic and US imaging with a modifi ed clinical US imaging system.
Materials and Methods
Three authors (T.N.E., L.J., M.D.P.) are employees of Philips Research North America (Briarcliff Manor, NY). Authors cancer patients. The combination of ultrasonography (US)-guided fi ne-needle aspiration biopsy (FNAB) and molecular analysis by using real-time reverse transcription-polymerase chain reaction is emerging as a viable, minimally invasive alternative to SLNB (10) (11) (12) (13) . Although axillary US imaging can provide morphologic information, such as size and shape of lymph nodes, it cannot be used to specifi cally identify SLNs, reducing the sensitivity of US-guided FNAB ( 14 ) . Noninvasive fl uorescence imaging has been used to identify SLNs by using indocyanine green dye (15) (16) (17) . Despite the use of nonionizing radiation, this technique requires surgical isolation of lymph nodes because of its poor depth penetration.
Photoacoustic imaging is a nonionizing and noninvasive hybrid imaging technique that can supply strong optical absorption contrasts with high US spatial resolution ( 18, 19 ) . Photoacoustic imaging relies on the photoacoustic effect for generating pressure waves under thermal and stress confi nement conditions. A short pulsed laser is used to irradiate tissue, causing optical absorption, rapid thermoelastic expansion, and acoustic pressure wave generation. For photoacoustic imaging in the diffusive regimen, spatial resolution is determined by the acoustic detector, and both image resolution and depth are highly scalable with the US frequency. Since US scattering is two to three orders of magnitude less than optical scattering on the basis of per-unit path length, photoacoustic imaging can break through the fundamental limitation of existing pure optical imaging (20) (21) (22) (23) . With the use of intrinsic contrast agents such as hemoglobin or melanin, photoacoustic tomography can be used to image both morphology (eg, vascular structures, angiogenesis, S entinel lymph node (SLN) biopsy (SLNB) has emerged as the preferred method for axillary lymph node staging of breast cancer patients with clinically negative axillary lymph nodes ( 1-3 ). The fi rst lymph nodes receiving drainage from the tumor are defi ned as SLNs and are most likely to be positive for metastases. The general process of SLNB includes the following: (a) identifi cation of SLNs by using radioactive colloids (eg, technetium 99m sulfur colloid) and invasive visual confi rmation of SLNs by using blue dyes (eg, isosulfan blue or methylene blue), (b) surgical resection of SLNs, and (c) histologic assessment of excised SLNs. If pathologic results for SLNs are negative, then full axillary lymph node dissection can be avoided. High identifi cation rates (90%-97%) and low false-negative rates (5%-10%) can be achieved with SLNB following injection of radioactive tracers and blue dye (4) (5) (6) .
Although SLNB aids in the reduction of morbidity and side effects, as compared with axillary lymph node dissection, it still remains an invasive surgical procedure with potential postoperative complications, which include lymphedema, seroma formation, sensory nerve injury, and range-of-motion limitations ( 7, 8 ) . In a clinical trial, researchers found that, in 74.2% (3989 of 5379) of breast cancer patients who underwent SLN resection, fi ndings were pathologically negative ( 9 ) . For most of the patients who undergo SLNB, a noninvasive or minimally invasive alternative could be used effectively for staging the axillary lymph nodes without requiring surgical intervention. Furthermore, with conventional SLNB, ionizing radiation is used to identify SLNs, so a solution without ionizing radiation would be advantageous.
The capability to noninvasively identify SLNs would allow targeted needle biopsies for defi nitive diagnosis in breast Implication for Patient Care
The dual-modality photoacoustic n and US imaging system can potentially be used clinically to guide fi ne-needle aspiration biopsies of SLNs for axillary lymph node staging in breast cancer patients.
Advance in Knowledge
Noninvasive photoacoustic and n US imaging can help in mapping rat sentinel lymph nodes (SLNs) and lymph vessels by using methylene blue dye in vivo. See also Science to Practice in this issue.
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B; Quantel, Les Ulis, France) with a 6.5-nanosecond pulse duration and a 10-Hz pulse repetition rate, was delivered through a high-temperature epoxy, multimode fi ber bundle (Schott Fiber Optics, Southbridge, Mass). The optical wavelength was tunable between 606 and 678 nm, which covered the peak optical absorption wavelength of methylene blue (667 nm). Unless otherwise noted, photoacoustic images were acquired by using 658-nm light. On the basis of the laser power spectrum, this wavelength produced the strongest photoacoustic signals from methylene blue. The light fl uence on the skin was less than 5 mJ/cm 2 , well within American National Standards Institute safety limits ( 38 ) .
The fi ber bundle was physically attached to a US probe to enable dualmodality photoacoustic and US imaging. The fi nal optical illumination pattern on the skin surface was rectangle shaped (3 3 1 cm along the x-axis and y-axis, respectively). The imaging plane of the US probe was coaxially aligned with the oblique incidence (approximately 45°) of the rectangle-shaped optical beam on the targeted area. The photoacoustic probe was partially immersed in a water tank, which had an opening at the bottom sealed with a thin, disposable, clear membrane. Rats system for image display and postprocessing, providing dual-modality imaging capability. Photoacoustic images were reconstructed by using a Fourier beamforming algorithm ( 37 ) implemented in software (Matlab; MathWorks, Natick, Mass), generating a photoacoustic B-mode image from one laser shot. A fi eld-programmable gate array-based electronic board synchronized data acquisition with the laser fi ring. Photoacoustic data capture at a frame rate of 10 frames per second was limited by the current laser repetition rate (described next) but ultimately can be enhanced to 50 frames per second with a suitable laser source. Beam-formed photoacoustic images can be displayed at a frame rate of approximately 1 frame per second, limited by image reconstruction.
The system can use all standard iU22 array transducers for both photoacoustic and US imaging. For this study, three focused US array transducers were used: the phased-array S5-1 probe (80 elements, 1-5 MHz) and two linear-array probes, L8-4 (128 elements, 4-8 MHz) and L15-7io (128 elements, 7-15 MHz).
Photoacoustic Imaging System
Light from a tunable dye laser (ND6000; Continuum, Santa Clara, Calif), pumped by a Q-switched Nd:YAG laser (Brilliant who are not employees of industry (C.K., L.V.W.) maintained control of the data that could have been a confl ict for the industry authors. One author (L.V.W.) has a fi nancial interest in Microphotoacoustics (Ronkonkoma, NY) and Endra (Ann Arbor, Mich), which, however, did not support this work.
Animal and Dye Preparation
Animal protocols were approved by the Animal Studies Committee, and animal handling was performed according to the Guide for the Care and Use of Laboratory Animals. Animal experiments were conducted between March 12, 2009, and May 26, 2009 . Seven healthy Sprague-Dawley rats (Harlan Laboratories, Indianapolis, Ind; weight range, 250-390 g) were initially anesthetized by using a mixture of ketamine (Ketaset, Fort Dodge Animal Health, Fort Dodge, Iowa) at a dose of 85 mg/kg and xylazine (AnaSed; Akorn, Decatur, Ill) at a dose of 15 mg/kg. The hair in the left axillary region was gently depilated before imaging. Photoacoustic and US images were collected before and after a 0.1-mL intradermal injection of a 1% (10 mg/mL) solution of methylene blue dye (American Regent, Shirley, NY), at 10 mg/mL, in the left forepaw pad. In the animals, full anesthesia was maintained throughout the experiment by using isofl urane gas, administered with 1 L/min of oxygen and 0.75% of isofl urane (Euthanex, Palmer, Pa). Simultaneously, both heart rate and saturation of peripheral oxygen were monitored by using a pulse oximeter (8600V; Nonin Medical, Plymouth, Minn). After imaging, animals were euthanized with an overdose of pentobarbital (Sleepaway; Fort Dodge Animal Health), and SLNs were dissected.
US Imaging System
A photoacoustic imaging system ( Fig 1 ) was built around a clinical US imaging system (iU22; Philips Healthcare, Andover, Mass) ( 36 ) . The modifi ed channel-board architecture allowed access to raw perchannel photoacoustic data, while all imaging capabilities of an actual commercial US scanner were retained. Raw photoacoustic and US data were transferred to a custom-built data acquisition 
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Erpelding et al from SLN regions before and after methylene blue injection. P values were computed from a one-tailed distribution and were considered to indicate a signifi cant difference if they were less than .05. Photoacoustic signal enhancement was defi ned as the ratio between post-and preinjection signal amplitudes from SLN regions. Photoacoustic contrast was defi ned as the ratio between signal amplitudes from SLNs and tissue background. Correlation coefficients were computed between measured photoacoustic spectra from SLNs and the optical absorption spectrum of methylene blue. All statistical analysis was performed by using software (Matlab; MathWorks) with statistical tools (Statistics Toolbox; MathWorks).
Results
Preinjection photoacoustic B-mode images feature photoacoustic signals from superfi cial blood vessels and skin surfaces. Soon after injection, methylene blue accumulates in SLNs, as detected photoacoustically ( Fig 2 ) . Preand postinjection images for each probe displayed with the same dynamic range demonstrate strong photoacoustic signal from SLNs following accumulation of methylene blue. Coregistered photoacoustic and US images demonstrate the capability to combine functional (photoacoustic) and structural (US) features for SLN mapping. A sample postmortem photograph of the rat axillary region imaged during experiments is shown in Figure 3 . The methylene blue-dyed SLN was visually identifi ed in the left axilla. Lymph nodes were typically 3 3 2 mm in size.
When imaging depth was increased by adding biologic tissue (either turkey or chicken breast tissue) on top of the rat skin surface, lymph nodes were imaged 2.4 cm and 2.5 cm below the top surface of the overlying tissue with the S5-1 ( Fig 4 ) and L8-4 probes, respectively. Optical spectra that were based on photoacoustic signals from SLNs closely matched the optical absorption spectrum of methylene blue, confi rming the presence of methylene blue in detected lymph nodes ( R = 0.995).
imaged by using the L8-4 probe. The photoacoustic probe was scanned by a motion controller (ILS200PP; Newport, Irvine, Calif) and translation stage (ESP300; Newport) in steps of 0.5 mm over a scanning distance of 2.5 cm, for a total fi eld of view of 2.3 3 2.5 3 5 cm. The total acquisition time for a 3D acquisition was 10 minutes. Photoacoustic maximum amplitude projection (MAP) images were reconstructed by fi rst removing the skin signal and then projecting the remaining maximum signal amplitude along each A-line onto the corresponding x -y plane. Volumetric photoacoustic images also were reconstructed by using software (VolView; Kitware, Clifton Park, NY).
Image Display
Coregistered images displayed photoacoustic signals by using a pseudo-color map ranging from blue to red over grayscale B-mode US images. Photoacoustic signals below a threshold value were suppressed in coregistered images to aid interpretation. The threshold value was 9% of the peak photoacoustic signal from the SLN for images acquired without additional overlying biologic tissue, whereas a threshold value of 30% was chosen for images with overlying tissue. Suitable threshold values were chosen on the basis of the signal-to-noise ratio of the photoacoustic signal from the SLN, which decreases at increasing depths.
Photoacoustic MAP images in the x-y plane were displayed before and after methylene blue injection. All MAP images were displayed by using the same dynamic range, color map, and magnification. A composite color map consisting of gray-scale and blue portions was chosen to easily visualize the blood vessels, the lymph vessels, and the lymph node in the same image. The blue color map displayed signal amplitudes greater than the maximum signal amplitude observed in the preinjection image to appreciate areas of enhanced signal amplitudes following methylene blue injection.
Statistical Analysis
Photoacoustic images were analyzed by using the nonparametric Wilcoxon signed rank test to compare signal amplitudes were placed below the water tank, in contact with the membrane by means of US coupling gel.
Experimental Procedures
Photoacoustic and US images were collected before and after methylene blue injection in seven healthy Sprague-Dawley rats. Photoacoustic monitoring of the SLN following methylene blue injection continued for a mean of 77 minutes 6 30 (standard deviation), with a range of 33-113 minutes. Of the seven rats, three were imaged with the L15-7io probe, two were imaged with the S5-1 probe, and two were imaged with the L8-4 probe.
Spectroscopic photoacoustic imaging can be used to determine the presence of methylene blue dye without the need for a preinjection baseline image. Spectroscopic photoacoustic imaging ( n = 7) was performed by using eight optical wavelengths between 607 and 678 nm to confi rm that measured photoacoustic spectra of SLNs matched the optical absorption spectrum of methylene blue ( 39 ) . Thirty photoacoustic images were collected at each optical wavelength to determine the effect of shot-to-shot variations in laser pulse energy.
To investigate clinical translation at deeper imaging depths in humans, 2 cm of biologic tissue (chicken or turkey breast) was added on top of the skin of two rats, one imaged with the S5-1 probe and one imaged with the L8-4 probe. Pre-and postinjection photoacoustic and US images were acquired with the added tissue in place. For spectroscopic photoacoustic imaging, the unknown optical attenuation spectrum of additional biologic tissue can affect the fl uence at the lymph node. Measured photoacoustic spectra from SLNs were normalized by the photoacoustic spectrum point by point from a small tube fi lled with methylene blue placed between the rat skin and the overlying tissue.
Three-dimensional (3D) photoacoustic images of SLNs and lymph vessels in three rats were acquired by mechanically scanning the photoacoustic probe along the elevational direction (y-axis). Two rats were imaged by using the L15-7io probe, and one was
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Erpelding et al increases by 30.6%, whereas the mean signal amplitude from the lymph vessel decreases by 48.6%. Signal amplitudes from blood vessels remained largely unchanged after injection. Photoacoustic signal amplitudes from SLNs increase signifi cantly following toacoustic signals from the lymph vessel and SLN increase six and 17 times from preinjection baseline amplitudes, respectively. As methylene blue travels from the lymph vessel to the SLN between 6 and 31 minutes after injection, the mean signal amplitude from the lymph node Three-dimensional photoacoustic images illustrate the propagation of methylene blue from lymph vessels to SLNs ( Fig 5 ) . Baseline MAP images acquired prior to methylene blue injection show the network of blood vessels in rat axillae. Soon after methylene blue injection, pho- 
Erpelding et al mJ/cm 2 ) ( 38 ). Because photoacoustic signal strength depends on optical fl uence and absorption, stronger optical fluence will enable photoacoustic SLN detection at even greater depths. Therefore, photoacoustic imaging should be capable of aiding in the noninvasive detection of axillary SLNs at most depths encountered in humans. Successful noninvasive photoacoustic mapping of rat SLNs through 2.5 cm of tissue motivates further evaluation of this technique and imaging devices in future trials in humans.
Our study had limitations. In current experiments, photoacoustic and US images are acquired in a water tank with the optical fi ber bundle positioned close to the US probe, which is mounted on a mechanical translation stage. For clinical translation, freehand US is preferred. In the next phase of development, light delivery will be integrated with the US probe to enable freehand scanning during photoacoustic and US image acquisition. In addition, 3D photoacoustic images were acquired by mechanically scanning the photoacoustic probe, resulting in slow acquisition times (approximately 10 minutes for a 2.3 3 2.5 3 5-cm fi eld of view). Faster 3D images could be obtained by using positional tracking of the transducer position during freehand scanning to accommodate larger fi elds of view. Finally, turkey and chicken breast tissue used to increase imaging depth may have lower blood content than human breast tissue. The penetration depth for photoacoustic imaging of SLNs will be more accurately assessed in human subjects during upcoming clinical experiments.
In summary, noninvasive photoacoustic and US mapping of rat SLNs and lymphatic vessels has been successfully demonstrated by using methylene blue dye with a modifi ed clinical US imaging system.
Practical application: The results from this study are an important step toward clinical translation of photoacoustic imaging for noninvasive SLN detection. Two key features of this technique are as follows: (a) The multimodality system for photoacoustic methylene blue injection ( P , .008). In fi ve rats in which measurements were made without overlying biologic tissue, the mean photoacoustic signal enhancement of SLNs at 20 minutes after injection was 32.7 6 7.2 (range, 25.3-41.8) from preinjection baseline signals, and the mean contrast of SLNs relative to tissue background was 76.0 6 23.7 (range, 46.1-112.2). In two rats in which measurements were made with overlaid biologic tissue, the photoacoustic signal enhancement values were 5.4 (S5-1 probe) and 3.7 (L8-4 probe), and the contrast values were 8.3 (S5-1 probe) and 4.6 (L8-4 probe).
Discussion
Noninvasive photoacoustic and US imaging have been used to map rat SLNs following methylene blue injection. This technique is highly translatable because it demonstrates photoacoustic detection of SLNs by using a modifi ed clinical US imaging system, and methylene blue is used clinically in the United States during SLNB. Three US probes were used to successfully image uptake of methylene blue in SLNs and enable selection according to imaging requirements. As in conventional US, photoacoustic imaging depends on US probe frequency and bandwidth to determine spatial resolution, depth penetration, and sensitivity.
Rat axillary lymph nodes are superfi cial, in most cases only 1.5-3.0 mm below the skin surface. Human axillary lymph nodes are deeper but larger. Photoacoustic SLN mapping was demonstrated at an imaging depth of 2.5 cm, without any signal averaging, by adding biologic tissue on top of the rat axillary skin. The investigators in a previous study ( 32 ) of photoacoustic SLN mapping in rats by using methylene blue reported a similar imaging depth of 2 cm without signal averaging and 3.1 cm with 50 times signal averaging. In the current study, optical fl uence on the skin was less than 5 mJ/cm 2 , which can be increased by a factor of four while still conforming to the maximal permissible exposure allowed by American National Standards Institute limits (20 
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